These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

490 related items for PubMed ID: 8053391

  • 1. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 2. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 3. Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.
    Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.
    J Bone Miner Res; 1997 Oct; 12(10):1729-36. PubMed ID: 9333135
    [Abstract] [Full Text] [Related]

  • 4. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.
    Ooms ME, Lips P, Roos JC, van der Vijgh WJ, Popp-Snijders C, Bezemer PD, Bouter LM.
    J Bone Miner Res; 1995 Aug 15; 10(8):1177-84. PubMed ID: 8585420
    [Abstract] [Full Text] [Related]

  • 6. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Aug 15; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 7. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P, Komulainen J, Riikonen P, Parviainen M, Jurvelin JS, Voutilainen R, Kröger H.
    J Bone Miner Res; 1999 Dec 15; 14(12):2002-9. PubMed ID: 10620058
    [Abstract] [Full Text] [Related]

  • 8. Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study.
    Lange U, Teichmann J, Müller-Ladner U, Strunk J.
    Rheumatology (Oxford); 2005 Dec 15; 44(12):1546-8. PubMed ID: 16263785
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF, Jensen JE, Eskildsen PC.
    Clin Endocrinol (Oxf); 2006 Dec 15; 65(6):783-91. PubMed ID: 17121531
    [Abstract] [Full Text] [Related]

  • 10. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep 15; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 11. Sequential analysis of biochemical markers of bone resorption and bone densitometry in multiple myeloma.
    Abildgaard N, Brixen K, Eriksen EF, Kristensen JE, Nielsen JL, Heickendorff L.
    Haematologica; 2004 May 15; 89(5):567-77. PubMed ID: 15136220
    [Abstract] [Full Text] [Related]

  • 12. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 13. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
    Valero C, Olmos JM, Rivera F, Hernández JL, Vega ME, Macías JG.
    Calcif Tissue Int; 2006 Jun 22; 78(6):343-7. PubMed ID: 16830204
    [Abstract] [Full Text] [Related]

  • 14. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E.
    Scand J Gastroenterol; 2003 Mar 22; 38(3):320-7. PubMed ID: 12737449
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral metabolism in adults with beta-thalassaemia major and intermedia.
    Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW.
    Br J Haematol; 2000 Dec 22; 111(3):902-7. PubMed ID: 11122154
    [Abstract] [Full Text] [Related]

  • 16. Is bone turnover a determinant of bone mass in rheumatoid arthritis?
    Cortet B, Flipo RM, Pigny P, Duquesnoy B, Boersma A, Marchandise X, Delcambre B.
    J Rheumatol; 1998 Dec 22; 25(12):2339-44. PubMed ID: 9858427
    [Abstract] [Full Text] [Related]

  • 17. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL, Loft AG, Møller N, Weeke J, Eriksen EF, Mosekilde L, Charles P.
    J Bone Miner Res; 1997 Jan 22; 12(1):78-88. PubMed ID: 9240729
    [Abstract] [Full Text] [Related]

  • 18. Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.
    Marcocci C, Golia F, Vignali E, Pinchera A.
    J Bone Miner Res; 1997 Jan 22; 12(1):72-7. PubMed ID: 9240728
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis.
    Chopin F, Garnero P, le Henanff A, Debiais F, Daragon A, Roux C, Sany J, Wendling D, Zarnitsky C, Ravaud P, Thomas T.
    Ann Rheum Dis; 2008 Mar 22; 67(3):353-7. PubMed ID: 17644538
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: effect of calcium supplementation with or without calcitonin.
    Välimäki MJ, Kinnunen K, Volin L, Tähtelä R, Löyttyniemi E, Laitinen K, Mäkelä P, Keto P, Ruutu T.
    Bone Marrow Transplant; 1999 Feb 22; 23(4):355-61. PubMed ID: 10100579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.